Paltusotine |
CRN-00808 |
Phase 3 Clinical |
Crinetics Pharmaceuticals Inc |
Acromegaly; Malignant Carcinoid Syndrome; Neuroendocrine Tumors |
Details
|
Lutetium-177 labelled edotreotide |
ITM-11 |
Phase 3 Clinical |
Universitaetsspitals Basel, Itm Solucin Gmbh |
Pancreatic neuroendocrine tumors (pNET); Neuroendocrine Tumors; Thymus Neoplasms; Lung Neoplasms |
Details
|
RYZ-101 |
RYZ-101 |
Phase 3 Clinical |
|
Carcinoid Tumor; Stomach Neoplasms; Pancreatic neuroendocrine tumors (pNET); Small Cell Lung Carcinoma; Neuroendocrine Tumors; Carcinoma, Neuroendocrine; Gastrointestinal Neoplasms |
Details
|
Gallium-68 satoreotide |
68Ga-OPS-202; 68Ga IPN-1070; 68Ga-DOTA-JR11 |
Phase 2 Clinical |
Ipsen Inc |
Stomach Neoplasms; Pancreatic neuroendocrine tumors (pNET); Small Cell Lung Carcinoma; Breast Neoplasms; Gastrointestinal Neoplasms |
Details
|
Nendratareotide uzatansine |
BTP-277; PEN-221 |
Phase 2 Clinical |
Tarveda Therapeutics Inc |
Small Cell Lung Carcinoma; Neuroendocrine Tumors; Carcinoma, Neuroendocrine |
Details
|
Yttrium 90-labelled edotreotide |
SMT-487-[90Y]; DOTATOC-[90Y] |
Phase 2 Clinical |
The University Of Iowa, Novartis Pharma Ag |
Central Nervous System Neoplasms; Meningioma; Melanoma; Lymphoma; Lung Neoplasms; Sarcoma; Neuroblastoma; Breast Neoplasms; Brain Neoplasms; Solid tumours; Neuroendocrine Tumors; Small Cell Lung Carcinoma; Adenoma, Islet Cell; Neoplasms; Pheochromocytoma; Carcinoid Tumor; Medulloblastoma |
Details
|
Dopastatin |
TBR-760; BIM-23A760 |
Phase 2 Clinical |
Ipsen |
Acromegaly; Malignant Carcinoid Syndrome; Adenoma; Pituitary Neoplasms |
Details
|
ZT-01 |
ZT 01; ZT-01 |
Phase 2 Clinical |
Tulane University, York University, University Of Toronto, Toronto |
Diabetes Mellitus, Type 1; Hypoglycemia |
Details
|
Re-188 P 2045 |
P2045; BAY-865284; Rhenium-188 P2045; Re-188 P 2045; Rh-188 P2045; Rhenium-188-P-2045 |
Phase 2 Clinical |
Bayer AG |
Neoplasm Recurrence, Local; Small Cell Lung Carcinoma; Neuroendocrine Tumors; Lung Neoplasms; Carcinoma, Small Cell; Carcinoma, Non-Small-Cell Lung |
Details
|
64Cu-SarTate |
|
Phase 2 Clinical |
University Of Melbourne |
Neuroendocrine Tumors; Neuroblastoma; Meningioma |
Details
|
Lutetium-177 DOTA satoreotide |
[177Lu]LuSSO110; 177Lu-IPN-1072; OPS-201; 177Lu-IPN01072; 177LU-OPS 201; 177Lu-DOTA- JR11; 177Lu-satoreotide |
Phase 1 Clinical |
Ipsen, OctreoPharm Sciences GmbH |
Small Cell Lung Carcinoma; Breast Neoplasms; Meningioma |
Details
|
CRN-01941 |
CRN-01941 |
Phase 1 Clinical |
Crinetics Pharmaceuticals Inc |
|
Details
|
68Ga-NOTA-3PTATE-RGD |
68Ga-NOTA-3PTATE-RGD; 68Ga-NOTA-3P-TATE-RGD |
Phase 1 Clinical |
Peking Union Medical College Hospital |
Small Cell Lung Carcinoma; Neuroendocrine Tumors; Lung Neoplasms |
Details
|
[99mTc]Tc-TECANT1 |
|
Phase 1 Clinical |
Ljubljana University Medical Centre, Medical University Of Innsbruck, Narodowe Centrum Badan Jadrowych, Jagiellonian University Sylff Fellows Association |
Neuroendocrine Tumors |
Details
|
161Tb-DOTA-LM3 |
161Tb-DOTA-LM3 |
Phase 1 Clinical |
University Hospital Basel |
Pancreatic neuroendocrine tumors (pNET); Neuroendocrine Tumors |
Details
|
[203-Pb] VMT-NET |
[203-Pb] VMT-NET |
Phase 1 Clinical |
Perspective Therapeutics Inc |
Neuroendocrine Tumors |
Details
|
44Sc-edotreotide |
44Sc-edotreotide; 44Sc-DOTA-[3-Tyr]-octreotide; Sc44-DOTATOC |
Clinical |
Zentralklinik Bad Berka |
Diagnostic agents |
Details
|
Paltusotine |
CRN-00808 |
Phase 3 Clinical |
Crinetics Pharmaceuticals Inc |
Acromegaly; Malignant Carcinoid Syndrome; Neuroendocrine Tumors |
Details
|
Lutetium-177 labelled edotreotide |
ITM-11 |
Phase 3 Clinical |
Universitaetsspitals Basel, Itm Solucin Gmbh |
Pancreatic neuroendocrine tumors (pNET); Neuroendocrine Tumors; Thymus Neoplasms; Lung Neoplasms |
Details
|
RYZ-101 |
RYZ-101 |
Phase 3 Clinical |
|
Carcinoid Tumor; Stomach Neoplasms; Pancreatic neuroendocrine tumors (pNET); Small Cell Lung Carcinoma; Neuroendocrine Tumors; Carcinoma, Neuroendocrine; Gastrointestinal Neoplasms |
Details
|
Gallium-68 satoreotide |
68Ga-OPS-202; 68Ga IPN-1070; 68Ga-DOTA-JR11 |
Phase 2 Clinical |
Ipsen Inc |
Stomach Neoplasms; Pancreatic neuroendocrine tumors (pNET); Small Cell Lung Carcinoma; Breast Neoplasms; Gastrointestinal Neoplasms |
Details
|
Nendratareotide uzatansine |
BTP-277; PEN-221 |
Phase 2 Clinical |
Tarveda Therapeutics Inc |
Small Cell Lung Carcinoma; Neuroendocrine Tumors; Carcinoma, Neuroendocrine |
Details
|
Yttrium 90-labelled edotreotide |
SMT-487-[90Y]; DOTATOC-[90Y] |
Phase 2 Clinical |
The University Of Iowa, Novartis Pharma Ag |
Central Nervous System Neoplasms; Meningioma; Melanoma; Lymphoma; Lung Neoplasms; Sarcoma; Neuroblastoma; Breast Neoplasms; Brain Neoplasms; Solid tumours; Neuroendocrine Tumors; Small Cell Lung Carcinoma; Adenoma, Islet Cell; Neoplasms; Pheochromocytoma; Carcinoid Tumor; Medulloblastoma |
Details
|
Dopastatin |
TBR-760; BIM-23A760 |
Phase 2 Clinical |
Ipsen |
Acromegaly; Malignant Carcinoid Syndrome; Adenoma; Pituitary Neoplasms |
Details
|
ZT-01 |
ZT 01; ZT-01 |
Phase 2 Clinical |
Tulane University, York University, University Of Toronto, Toronto |
Diabetes Mellitus, Type 1; Hypoglycemia |
Details
|
Re-188 P 2045 |
P2045; BAY-865284; Rhenium-188 P2045; Re-188 P 2045; Rh-188 P2045; Rhenium-188-P-2045 |
Phase 2 Clinical |
Bayer AG |
Neoplasm Recurrence, Local; Small Cell Lung Carcinoma; Neuroendocrine Tumors; Lung Neoplasms; Carcinoma, Small Cell; Carcinoma, Non-Small-Cell Lung |
Details
|
64Cu-SarTate |
|
Phase 2 Clinical |
University Of Melbourne |
Neuroendocrine Tumors; Neuroblastoma; Meningioma |
Details
|
Lutetium-177 DOTA satoreotide |
[177Lu]LuSSO110; 177Lu-IPN-1072; OPS-201; 177Lu-IPN01072; 177LU-OPS 201; 177Lu-DOTA- JR11; 177Lu-satoreotide |
Phase 1 Clinical |
Ipsen, OctreoPharm Sciences GmbH |
Small Cell Lung Carcinoma; Breast Neoplasms; Meningioma |
Details
|
CRN-01941 |
CRN-01941 |
Phase 1 Clinical |
Crinetics Pharmaceuticals Inc |
|
Details
|
68Ga-NOTA-3PTATE-RGD |
68Ga-NOTA-3PTATE-RGD; 68Ga-NOTA-3P-TATE-RGD |
Phase 1 Clinical |
Peking Union Medical College Hospital |
Small Cell Lung Carcinoma; Neuroendocrine Tumors; Lung Neoplasms |
Details
|
[99mTc]Tc-TECANT1 |
|
Phase 1 Clinical |
Ljubljana University Medical Centre, Medical University Of Innsbruck, Narodowe Centrum Badan Jadrowych, Jagiellonian University Sylff Fellows Association |
Neuroendocrine Tumors |
Details
|
161Tb-DOTA-LM3 |
161Tb-DOTA-LM3 |
Phase 1 Clinical |
University Hospital Basel |
Pancreatic neuroendocrine tumors (pNET); Neuroendocrine Tumors |
Details
|
[203-Pb] VMT-NET |
[203-Pb] VMT-NET |
Phase 1 Clinical |
Perspective Therapeutics Inc |
Neuroendocrine Tumors |
Details
|
44Sc-edotreotide |
44Sc-edotreotide; 44Sc-DOTA-[3-Tyr]-octreotide; Sc44-DOTATOC |
Clinical |
Zentralklinik Bad Berka |
Diagnostic agents |
Details
|